Royal Bank of Canada »

Emergent BioSolutions shares owned by Royal Bank of Canada

Quarter-by-quarter ownership of Emergent BioSolutions (EBS) shares owned by Royal Bank of Canada from 13F filings

Historical chart of Royal Bank of Canada investment in Emergent BioSolutions

Tip: Access up to 7 years of quarterly data

All positions including Emergent BioSolutions held by Royal Bank of Canada consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Emergent BioSolutions by Royal Bank of Canada

Quarter filed Position value Share count Share price at filing
2011-09-30 $419k 27k 15.42
2011-06-30 $122k 5.4k 22.50

More positions owned by Royal Bank of Canada

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Rbc Cad (RY)
Ishares Tr Core S&p500 Etf (IVV)
Toronto Dominion Bk Ont Com New (TD)
Bank Of Montreal Cadcom (BMO)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Alphabet Cap Stk Cl A (GOOGL)
Bk Nova Cad (BNS)
JPMorgan Chase & Co. (JPM)
Enbridge (ENB)
Cibc Cad (CM)

View all positions for Royal Bank of Canada

Top funds holding Emergent BioSolutions

Vanguard Group
American Century Companies
State Street Corporation
BlackRock
Invesco
Millennium Management
Marshall Wace
Charles Schwab Investment Management
Morgan Stanley
Susquehanna International
Oak Hill Advisors
Dimensional Fund Advisors
Goldman Sachs Group
Palisade Capital Management
Connor, Clark & Lunn Investment Management

View all funds holding Emergent BioSolutions